닫기
검색

ScienceON 논문 검색

  • home
  • ScienceON 논문 검색
search

검색어 : 통합검색[Levine Adam]

979건 중 979건 출력

, 92/98 페이지

  • 911
    Low vs high dose carfilzomib (Cfz) with dexamethasone (Dex) for relapsed/refractory multiple myeloma (RRMM): Results of SWOG S1304.
    Ailawadhi, Sikander; Sexton, Rachael; Lentzsch, Suzanne; Abidi, Muneer Hyder; Voorhees, Peter Michael; Cohen, Adam D.; Rohren, Eric; Heitner, Stephen; Kelly, Kevin; Mackler, Niklas J.; Baer, David M.; Hoering, Antje; Durie, Brian G.; Orlowski, Robert Z.; Mayo Clinic, Jacksonville, FL; ; Cancer Research and Biostatistics, Seattle, WA; ; Columbia University Medical Center, New York, NY; ; Spectrum Health, Ada, MI; ; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; ; Abramson Cancer Center, Philadelphia, PA; ; The University of Texas MD Anderson Cancer Center, Houston, TX; ; Oregon Health & Science University, Portland, OR; ; University of Southern California, Norris Cancer Center Hospital, Los Angeles, CA; ; IHA Hem/ Onc, Ann Arbor, MI; ; Kaiser Permanente, Oakland, CA; ; Cancer Research and Biostatistics, Seattle, WA; ; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; ; The University of Texas MD Anderson Cancer Center, Houston, TX; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.36, 2018, pp.8015-8015)
  • 912
    Physicians’ Perspectives on Presurgical Discussion and Shared Decision-Making in Pediatric Epilepsy Surgery
    Samanta, Debopam; Ostendorf, Adam P; Singh, Rani; Gedela, Satyanarayana; Elumalai, Vimala; Hoyt, Megan Leigh; Perry, M. Scott; Bartolini, Luca; Curran, Geoffrey M; Neurology Division, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Division of Neurology, Department of Pediatrics, The Ohio State University and Nationwide Children’s Hospital, Columbus, OH, USA; Department of Pediatrics, Atrium Health/Levine Children’s Hospital, Concord, NC, USA; Department of Pediatrics, Emory University College of Medicine, Atlanta, GA, USA; Division of Neurology, Arkansas Children’s Hospital, Little Rock, AR, USA; Division of Neurology, Arkansas Children’s Hospital, Little Rock, AR, USA; Justin Neurosciences Center, Cook Children’s Medical Center, Fort Worth, TX, USA; Department of Pediatrics, The Warren Alpert Medical School of Brown University, Providence, RI, USA; College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, USA; (Journal of child neurology, v.37, 2022, pp.416-425)
  • 913
    Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma
    Ailawadhi, Sikander; Sexton, Rachael; Lentzsch, Suzanne; Abidi, Muneer H.; Voorhees, Peter M.; Cohen, Adam D.; Rohren, Eric M.; Heitner, Stephen; Kelly, Kevin; Mackler, Niklas J.; Baer, David M.; Hoering, Antje; Durie, Brian; Orlowski, Robert Z.; Mayo Clinic, Jacksonville, Florida.; Cancer Research and Biostatistics, Seattle, Washington.; Columbia University Medical Center, New York, New York.; Spectrum Health/Michigan State University, Grand Rapids, Michigan.; Levine Cancer Institute, Charlotte, North Carolina.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.; Baylor College of Medicine, Houston, Texas.; Oregon Health & Science University, Portland, Oregon.; Norris Comprehensive Cancer Center, Los Angeles, California.; IHA Hem/Onc, Ann Arbor, Michigan.; Kaiser Permanente, Oakland, California.; Cancer Research and Biostatistics, Seattle, Washington.; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, California.; The University of Texas MD Anderson Cancer Center, Houston, Texas.; (Clinical Cancer research : an official journal of the American Association for Cancer Research, v.26, 2020, pp.3969-3978)
  • 914
    Antibody–drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study
    Trudel, Suzanne; Lendvai, Nikoletta; Popat, Rakesh; Voorhees, Peter M.; Reeves, Brandi; Libby, Edward N.; Richardson, Paul G.; Hoos, Axel; Gupta, Ira; Bragulat, Veronique; He, Zangdong; Opalinska, Joanna B.; Cohen, Adam D.; Princess Margaret Cancer Centre, Toronto, ON Canada; Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY USA; NIHR/University College London Hospital Clinical Research Facility, NHS Foundation Trust, London, UK; Levine Cancer Institute, Atrium Health, Charlotte, NC USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC USA; University of Washington, Seattle, WA USA; Dana-Farber Cancer Institute, Boston, MA USA; GSK, Philadelphia, PA USA; GSK, Philadelphia, PA USA; GSK, Philadelphia, PA USA; GSK, Philadelphia, PA USA; GSK, Philadelphia, PA USA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA USA; (Blood cancer journal, v.9, 2019, pp.37)
  • 915
    Enrichment of alterations in targetable molecular pathways in KRAS wild-type (WT) pancreatic cancer (PC).
    Philip, Philip Agop; Xiu, Joanne; Hall, Michael J.; Hendifar, Andrew Eugene; Lou, Emil; Hwang, Jimmy J.; Gong, Jun; Khushman, Moh'd M.; Sohal, Davendra; Lockhart, A. Craig; Weinberg, Benjamin Adam; Marshall, John; Grothey, Axel; Shields, Anthony Frank; Korn, Wolfgang Michael; Karmanos Cancer Institute, Detroit, MI; ; Caris Life Sciences, Phoenix, AZ; ; Fox Chase Cancer Center, Philadelphia, PA; ; Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA; ; University of Minnesota School of Medicine, Minneapolis, MN; ; Levine Cancer Institute, Charlotte, NC; ; City of Hope, Duarte, CA; ; Medical Oncology, The University of South Alabama, Mitchell Cancer Institute, Mobile, AL; ; University of Cincinnati, Cincinnati, OH; ; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL; ; Georgetown University, Washington, DC; ; Georgetown University, Washington, DC; ; West Cancer Center, Germantown, TN; ; Karmanos Cancer Institute, Wayne State University, Detroit, MI; ; Caris Life Sciences, Phoenix, AZ; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.38, 2020, pp.4629-4629)
  • 916
    Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study
    Richardson, Paul G.; Lee, Hans C.; Abdallah, Al-Ola; Cohen, Adam D.; Kapoor, Prashant; Voorhees, Peter M.; Hoos, Axel; Wang, Karrie; Baron, January; Piontek, Trisha; Byrne, Julie; Richmond, Scott; Jewell, Roxanne C.; Opalinska, Joanna; Gupta, Ira; Lonial, Sagar; Dana Farber Cancer Institute, Boston, MA USA; MD Anderson Cancer Center, Houston, TX USA; University of Kansas Cancer Center, Fairway, KS USA; Abramson Cancer Center, University of Philadelphia, Philadelphia, PA USA; Mayo Clinic, Rochester, MN USA; Levine Cancer Institute, Atrium Health, Charlotte, NC USA; GlaxoSmithKline, Philadelphia, PA USA; GlaxoSmithKline, Philadelphia, PA USA; GlaxoSmithKline, Philadelphia, PA USA; GlaxoSmithKline, Philadelphia, PA USA; GlaxoSmithKline, Philadelphia, PA USA; GlaxoSmithKline, Rockville, MD USA; GlaxoSmithKline, Research Triangle Park, NC USA; GlaxoSmithKline, Philadelphia, PA USA; GlaxoSmithKline, Philadelphia, PA USA; Emory University, Winship Cancer Institute, Atlanta, GA USA; (Blood cancer journal, v.10, 2020, pp.106)
  • 917
    Treatment Patterns and Outcomes for Patients with Classic Hodgkin Lymphoma (cHL) and Cardiomyopathy with Low Ejection Fraction (EF): Real-World Evidence (RWE) from 16 US Academic Centers
    Annunzio, Kaitlin; McLaughlin, Eric; Voorhees, Timothy; Shea, Lauren Kelly; Sumransub, Nuttavut; Rose, Ashley; Olszewski, Adam J; Bailey, Neil; Patel, Krish; Moyo, Tamara K.; Awan, Farrukh T.; Ahmed, Gulrayz; Grover, Natalie S.; Adika, Adam; Andres, Erica L; Faisal, Muhammad Salman; Christian, Beth; Anna, Jacob; Bair, Steven M.; Kendsersky, Nicholas; Thomas, Colin; Torka, Pallawi; Svoboda, Jakub; Carter, Jordan S; Hamadani, Mehdi; Saeed, Hayder; Desai, Sanjal H.; Evens, Andrew M; Epperla, Narendranath; 1The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH; 2Center for Biostatistics, The Ohio State University, Columbus, OH; 3Department of Hematology, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH; 4O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL; 5Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN; 6H Lee Moffitt Cancer Center and Research Institute, Tampa, FL; 7Brown University, Providence, RI; 8Swedish Cancer Institute, Seattle, WA; 8Swedish Cancer Institute, Seattle, WA; 9Atrium Health / Levine Cancer Institute, Charlotte, NC; 10University of Texas Southwestern Medical Center, Dallas; 11Medical College of Wisconsin, Milwaukee, WI; 12Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; 13Temple University Hospital, Philadelphia, PA; 14University of Pennsylvania, Phila; (Blood, v.142, 2023, pp.382-382)
  • 918
    Characterizing the US Patient Population Receiving Rituximab with Gemcitabine and Oxaliplatin (R-GemOx) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Using Real-World Data
    Budde, Lihua E.; Olszewski, Adam J.; Hu, Bei; Shah, Nikesh; Batlevi, Connie Lee; Yin, Shen; To, Iris; Wei, Michael C.; Kallemeijn, Martine; Orellana-Noia, Victor; Musick, Lisa; Shamas, Natasha; Pal, Navdeep; Shewade, Ashwini; Westin, Jason R.; 1City of Hope National Medical Center, Duarte, CA; 2Brown University, Providence, RI; 3Atrium Health Levine Cancer Institute, Wake Forest School of Medicine, Charlotte, NC; 4Tampa General Hospital Cancer Institute, Tampa, FL; 5Genentech, Inc., South San Francisco, CA; 5Genentech, Inc., South San Francisco, CA; 5Genentech, Inc., South San Francisco, CA; 5Genentech, Inc., South San Francisco, CA; 6F. Hoffmann-La Roche Ltd, Basel, Switzerland; 5Genentech, Inc., South San Francisco, CA; 5Genentech, Inc., South San Francisco, CA; 5Genentech, Inc., South San Francisco, CA; 5Genentech, Inc., South San Francisco, CA; 5Genentech, Inc., South San Francisco, CA; 7The University of Texas MD Anderson Cancer Center, Houston, TX; (Blood, v.144, 2024, pp.2373-2373)
  • 919
    <i>NRG1</i> fusions in solid tumors.
    Gupta, Brinda; Wu, Sharon; Ou, Sai-Hong Ignatius; Darabi, Sourat; Mileham, Kathryn Finch; Gandhi, Nishant; Weinberg, Benjamin Adam; Nagasaka, Misako; Borghaei, Hossein; Ma, Patrick C.; Farrell, Alex Patrick; Sledge, George W.; Vanderwalde, Ari M.; El-Deiry, Wafik S.; Liu, Stephen V.; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Caris Life Sciences, Phoenix, AZ; Chao Family Comp Cancer Ctr, Orange, CA; Hoag Memor Hosp, Newport Beach, CA; Levine Cancer Institute, Charlotte, NC; Caris Life Sciences Research and Development, Phoenix, AZ; Georgetown University Medical Center, Washington, DC; University of California Irvine School of Medicine, Orange, CA; Fox Chase Cancer Center, Philadelphia, PA; Penn State Milton S. Hershey Medical Center, Hershey, PA; Caris Life Sciences, Phoenix, AZ; Caris Life Sciences, Phoenix, AZ; West Cancer Center and Research Institute, Caris Life Sciences, Germantown and Memphis, TN; Brown University, Providence, RI; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.41, 2023, pp.3132-3132)
  • 920
    Abstract 13448: Time Course and Predictors of Renal Function Decline After Pediatric Heart Transplantation: A PHTS Multi-Institutional Analysis
    Varma, Manu R; Richmond, Marc E; Koehl, Devin A; Aljohani, Othman A; Exil, Vernat J; Morrison, Adam K; Sheybani, Aryaz; White, Shelby; Cantor, Ryan S; Kirklin, James K; Eghtesady, Pirooz; Program for Pediatric Cardiomyopathy, Heart Failure and Transplantation, Morgan Stanley Children's Hosp of New York Presbyterian, New York, NY; Program for Pediatric Cardiomyopathy, Heart Failure and Transplantation, Morgan Stanley Children's Hosp of New York Presbyterian, New York, NY; Kirklin Institute for Rsch in Surgical Outcomes, Birmingham, AL; Div of Pediatric Cardiology, UCSF Benioff Children's Hosp, San Francisco, CA; Saint Louis Univ, Saint Louis, MO; Pediatric Heart Failure & Heart Transplant Cardiology, Atrium Health Levine Children’s Hosp, Charlotte, NC; Vanderbilt Children's Hosp, Nashville, TN; Univ of Virginia, Charlottesville, VA; Kirklin Institute for Rsch in Surgical Outcomes, Birmingham, AL; Kirklin Institute for Rsch in Surgical Outcomes, Birmingham, AL; Washington Univ St. Louis, Saint Louis, MO; (Circulation, v.146, 2022, )

처음 오셨나요?